Literature DB >> 8678109

Retroviruses and schizophrenia revisited.

R L O'Reilly1, S M Singh.   

Abstract

Both genetic and environmental factors appear to contribute to the causation of schizophrenia. Evidence indicating that fetal development is disrupted in schizophrenia and the finding of an excess of winter births among schizophrenic patients have led to continued speculation that an intrauterine viral infection may cause developmental lesions, genetic mutations, or persistent infections that lead to schizophrenia. Certain unique characteristics of the retroviruses render them plausible as candidate "schizoviruses" and the involvement of an endogenous retrovirus would be compatible with some of the puzzling epidemiological findings in schizophrenia. Reverse transcriptase (RT) is a retrovirally encoded enzyme essential for retroviral integration into host DNA. While attempts to detect retroviral infections by measuring RT activity in the peripheral lymphocytes and serum of schizophrenic patients have been unsuccessful, such negative findings may simply mean that the virus is not active in peripheral lymphocytes. A more sensitive and comprehensive approach to detect a retrovirus is to search the genomes of schizophrenic patients directly for the presence of retroviral DNA sequences encoding RT and one possible approach is described.

Entities:  

Mesh:

Year:  1996        PMID: 8678109     DOI: 10.1002/(SICI)1096-8628(19960216)67:1<19::AID-AJMG3>3.0.CO;2-N

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

1.  Retroviruses and the pathogenesis of schizophrenia.

Authors:  D A Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 2.  Search for missing schizophrenia genes will require a new developmental neurogenomic perspective.

Authors:  H B Kiran Kumar; Christina Castellani; Sujit Maiti; Richard O'Reilly; Shiva M Singh
Journal:  J Genet       Date:  2013       Impact factor: 1.166

3.  Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia.

Authors:  H Karlsson; S Bachmann; J Schröder; J McArthur; E F Torrey; R H Yolken
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 4.  Molecular genetics of schizophrenia: past, present and future.

Authors:  Suman Prasad; Prachi Semwal; Smita Deshpande; Triptish Bhatia; V L Nimgaonkar; B K Thelma
Journal:  J Biosci       Date:  2002-02       Impact factor: 1.826

5.  Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders.

Authors:  Oliver Frank; Michelle Giehl; Chun Zheng; Rüdiger Hehlmann; Christine Leib-Mösch; Wolfgang Seifarth
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 6.  Interleukin 18 in the CNS.

Authors:  Silvia Alboni; Davide Cervia; Shuei Sugama; Bruno Conti
Journal:  J Neuroinflammation       Date:  2010-01-29       Impact factor: 8.322

7.  RNA from Borna disease virus in patients with schizophrenia, schizoaffective patients, and in their biological relatives.

Authors:  Sandra Odebrechet Vargas Nunes; Eiko Nakagawa Itano; Marla Karine Amarante; Edna Maria Vissoci Reiche; Helen Cristina Miranda; Carlos Eduardo Coral de Oliveira; Tiemi Matsuo; Heber Odebrechet Vargas; Maria Angelica Ehara Watanabe
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

Review 8.  Theories of schizophrenia: a genetic-inflammatory-vascular synthesis.

Authors:  Daniel R Hanson; Irving I Gottesman
Journal:  BMC Med Genet       Date:  2005-02-11       Impact factor: 2.103

Review 9.  Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?

Authors:  Joseph M Antony; Andre M Deslauriers; Rakesh K Bhat; Kristofer K Ellestad; Christopher Power
Journal:  Biochim Biophys Acta       Date:  2010-08-06

10.  DNA methylation and mRNA expression of SYN III, a candidate gene for schizophrenia.

Authors:  Brenda C Murphy; Richard L O'Reilly; Shiva M Singh
Journal:  BMC Med Genet       Date:  2008-12-22       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.